Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 40, 3043-3045, August 1, 1980]
© 1980 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pettit, W. A.
Right arrow Articles by Goldenberg, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pettit, W. A.
Right arrow Articles by Goldenberg, D. M.

Radiolabeling of Affinity-purified Goat Anti-Carcinoembryonic Antigen Immunoglobulin G with Technetium-99m1

William A. Pettit2, Frank H. DeLand, Sidney J. Bennett and David M. Goldenberg

Nuclear Medicine Service, Veterans Administration Medical Center, Lexington 40507 [W. A. P., F. H. D.], and Division of Experimental Pathology, Department of Pathology, University of Kentucky Medical Center, and Ephraim McDowell Community Cancer Network, Inc., Lexington, Kentucky 40536 [S. J. B., D. M. G.]

Affinity-purified goat anti-carcinoembryonic antigen immunoglobulin G was labeled with 99mTc, utilizing stannous tartrate as the reducing agent. The radiochemical yield of labeled antibody ranged from 18 to 37% and was inversely proportional to the initial quantity of pertechnetate ion used. Yields up to 60% could be obtained using small amounts of pertechnetate. the 99mTc-labeled anti-carcinoembryonic antigen immunoglobulin G preparations had a specific activity range of 1 to 6 µCi/µg protein and had 60% or greater immunoreactivity. Human serum albumin and goat immunoglobulin G were used as model systems to evaluate labeling parameters and analytical methods.

1 Presented at the UICC Workshop on Radioimmunodetection of Cancer, July 19 to 21, 1979, Lexington, Ky. Supported in part by NIH Grants CA-17742 and CA-25584, NIH Contract NIC-N01-CB-64011-35, and by a grant from the Veterans Administration.

2 To whom requests for reprints should be addressed.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1980 by the American Association for Cancer Research.